Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.
about
Emerging treatment options for nasopharyngeal carcinomaTherapeutic implications of Epstein-Barr virus infection for the treatment of nasopharyngeal carcinomaTreatment of nasopharyngeal carcinoma using simultaneous modulated accelerated radiation therapy via helical tomotherapy: a phase II study.PET/CT-guided dose-painting versus CT-based intensity modulated radiation therapy in locoregional advanced nasopharyngeal carcinoma.Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas.A Randomized Pilot Trial Comparing Position Emission Tomography (PET)-Guided Dose Escalation Radiotherapy to Conventional Radiotherapy in Chemoradiotherapy Treatment of Locally Advanced Nasopharyngeal Carcinoma.Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment Toxicities.The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy.Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy.Intensity modulated radiotherapy (IMRT) combined with concurrent but not adjuvant chemotherapy in primary nasopharyngeal cancer - a retrospective single center analysisComparison of long-term survival and toxicity of simultaneous integrated boost vs conventional fractionation with intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma.A phase II trial of neoadjuvant IMRT-based chemoradiotherapy followed by one cycle of capecitabine for stage II/III rectal adenocarcinomaLASSO-based NTCP model for radiation-induced temporal lobe injury developing after intensity-modulated radiotherapy of nasopharyngeal carcinomaRadiation-induced temporal lobe injury for nasopharyngeal carcinoma: a comparison of intensity-modulated radiotherapy and conventional two-dimensional radiotherapy.The Clinical Usefulness of (18)F-Fluorodeoxyglucose Positron Emission Tomography (PET) to Predict Oncologic Outcomes and PET-Based Radiotherapeutic Considerations in Locally Advanced Nasopharyngeal Carcinoma.Long-term patterns of relapse and survival following definitive intensity-modulated radiotherapy for non-endemic nasopharyngeal carcinoma.Critical analysis of locoregional failures following intensity-modulated radiotherapy for nasopharyngeal carcinoma.Lymph node standardized uptake values at pre-treatment 18F-fluorodeoxyglucose positron emission tomography as a valuable prognostic factor for distant metastasis in nasopharyngeal carcinoma.Induction chemotherapy followed by intensity-modulated radiotherapy with reduced gross tumor volume delineation for stage T3-4 nasopharyngeal carcinomaRadiation-induced lower cranial nerve palsy in patients with head and neck carcinoma.Propensity score matching analysis of a phase II study on simultaneous modulated accelerated radiation therapy using helical tomotherapy for nasopharyngeal carcinomas.IMRT: preliminary results in a series of advanced head-and-neck cancer patients.Intensity-modulated radiation therapy for T4 nasopharyngeal carcinoma. Treatment results and locoregional recurrence.Prognostic variables for temporal lobe injury after intensity modulated-radiotherapy of nasopharyngeal carcinoma.
P2860
Q26995560-0C9DE4D8-79E0-462D-AF14-DE61D1F8A503Q27016002-CC95D5AC-9F83-4BE3-B953-351DE5CE7A24Q33432643-819EEC1B-049C-4891-B3C1-4762CF20D641Q33771373-13FBE24B-DBE4-442A-B219-5AD854BAEC7FQ33907143-8F5201AA-9703-45CD-A016-0093BA84D34DQ35542369-CD72B030-B0FD-446B-9684-122738C118CDQ35683086-6AB42ACC-A701-412C-BCFA-786907B0A189Q35870838-81EB04D7-F1AF-4AD4-8E3C-34C57316D755Q36546073-20018C42-298A-4808-985F-805CD9A4D1E9Q36614113-AD1EB4D5-97DA-419D-A2E1-3BE8019143F7Q36690259-CB665DD1-34D9-4C26-A0D2-CFFF46980CFEQ36766858-53F8248E-AF4C-4A87-90D3-AF2FAB49AB1FQ36922653-58020CB7-E6D2-4C9E-B9DB-83053D3CE356Q36925550-723F828D-D378-4EB9-ABF4-5D2955E7A37FQ37001059-67CE1076-D846-407D-BFEA-E392B2162AB5Q37097507-638BA968-6D2C-41C3-9871-AA75A12B3741Q37156590-2D6AD27A-D0A6-4F3F-A12B-92F18B1E7D96Q39501001-BC1651F0-982D-43A1-A49B-83605DE337D9Q40410720-0642FE55-633B-47CB-8734-29B8B0E30104Q40983645-8225563C-5ECB-4725-8AC1-511311AB1949Q41553766-2D14103F-F74B-482C-8683-F23D0976EC3BQ41554686-967B541B-B560-4E3D-AEC5-AB2F53DC5810Q42510603-923EA4EB-A539-4FF6-B148-72A55A5F0D35Q44070282-9E89CB76-8C94-410B-9D54-4695803347B7Q55154377-6D43B587-07B1-4D43-AD82-FA6E1C228705
P2860
Hypofractionated dose-painting intensity modulated radiation therapy with chemotherapy for nasopharyngeal carcinoma: a prospective trial.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hypofractionated dose-painting ...... arcinoma: a prospective trial.
@ast
Hypofractionated dose-painting ...... arcinoma: a prospective trial.
@en
Hypofractionated dose-painting ...... arcinoma: a prospective trial.
@nl
type
label
Hypofractionated dose-painting ...... arcinoma: a prospective trial.
@ast
Hypofractionated dose-painting ...... arcinoma: a prospective trial.
@en
Hypofractionated dose-painting ...... arcinoma: a prospective trial.
@nl
prefLabel
Hypofractionated dose-painting ...... arcinoma: a prospective trial.
@ast
Hypofractionated dose-painting ...... arcinoma: a prospective trial.
@en
Hypofractionated dose-painting ...... arcinoma: a prospective trial.
@nl
P2093
P2860
P1476
Hypofractionated dose-painting ...... arcinoma: a prospective trial.
@en
P2093
David G Pfister
Dennis H Kraus
Richard L Bakst
Suzanne L Wolden
P2860
P304
P356
10.1016/J.IJROBP.2010.01.026
P407
P577
2010-06-03T00:00:00Z